Total Payments
$608.55
2023 Payments
$124.98
Companies
6
Transactions
13
Medicare Patients
940
Medicare Billing
$184,132
Payment Breakdown by Category
Food & Beverage$608.55 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $608.55 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $155.98 | 7 | $0 (2020) |
| Organogenesis Inc. | $140.69 | 1 | $0 (2022) |
| Allergan Inc. | $128.22 | 1 | $0 (2019) |
| Grifols USA, LLC | $124.98 | 1 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $39.39 | 2 | $0 (2021) |
| Acacia Pharma Inc | $19.29 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $124.98 | 1 | Grifols USA, LLC ($124.98) |
| 2022 | $140.69 | 1 | Organogenesis Inc. ($140.69) |
| 2021 | $58.68 | 3 | Collegium Pharmaceutical, Inc. ($39.39) |
| 2020 | $73.47 | 1 | Merck Sharp & Dohme Corporation ($73.47) |
| 2019 | $174.96 | 4 | Allergan Inc. ($128.22) |
| 2018 | $24.45 | 2 | Merck Sharp & Dohme Corporation ($24.45) |
| 2017 | $11.32 | 1 | Merck Sharp & Dohme Corporation ($11.32) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2023 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Immunology | ||||||
| 11/03/2022 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $140.69 | General |
| Category: WOUND CARE | ||||||
| 05/18/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| Category: Opioid Analgesic | ||||||
| 05/15/2021 | Acacia Pharma Inc | BYFAVO (Drug), BARHEMSYS | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Anesthesiology | ||||||
| 03/11/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.44 | General |
| Category: Opioid Analgesic | ||||||
| 01/22/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $73.47 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/12/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/11/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $128.22 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/02/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/17/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/20/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/19/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/31/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 244 | 603 | $143,660 | $47,020 |
| 2022 | 6 | 174 | 499 | $119,276 | $35,604 |
| 2021 | 5 | 210 | 582 | $148,546 | $44,751 |
| 2020 | 6 | 312 | 774 | $182,737 | $56,757 |
Total Patients
940
Total Services
2,458
Medicare Billing
$184,132
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 208 | $55,328 | $19,035 | 34.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 76 | 279 | $51,615 | $16,965 | 32.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 82 | 83 | $22,659 | $7,189 | 31.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $7,740 | $2,034 | 26.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $6,318 | $1,797 | 28.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 53 | 194 | $51,604 | $15,263 | 29.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 105 | $19,425 | $5,773 | 29.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 15 | 97 | $17,072 | $5,272 | 30.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 11 | 44 | $10,208 | $3,109 | 30.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 38 | 39 | $10,647 | $3,102 | 29.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $10,320 | $3,084 | 29.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 74 | 339 | $90,174 | $27,154 | 30.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 46 | 152 | $28,120 | $8,476 | 30.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 33 | 33 | $17,028 | $5,138 | 30.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 28 | 28 | $7,644 | $2,346 | 30.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 29 | 30 | $5,580 | $1,638 | 29.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 87 | 294 | $78,204 | $24,565 | 31.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 105 | 359 | $66,415 | $20,523 | 30.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 29 | 30 | $15,480 | $4,837 | 31.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 41 | 41 | $11,193 | $3,506 | 31.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 37 | 37 | $6,882 | $2,164 | 31.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 13 | 13 | $4,563 | $1,162 | 25.5% |
About Dr. Ali Raoof, MD
Dr. Ali Raoof, MD is a Internal Medicine healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1699013649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ali Raoof, MD has received a total of $608.55 in payments from pharmaceutical and medical device companies, with $124.98 received in 2023. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($608.55).
As a Medicare-enrolled provider, Raoof has provided services to 940 Medicare beneficiaries, totaling 2,458 services with total Medicare billing of $184,132. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Tucson, AZ
- Active Since 01/26/2013
- Last Updated 01/26/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699013649
Products in Payments
- ZERBAXA (Drug) $155.98
- Puraply (Medical Supply) $140.69
- AVYCAZ (Drug) $128.22
- HyperRAB (Biological) $124.98
- XTAMPZA (Drug) $39.39
- BYFAVO (Drug) $19.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tucson
Dr. Rajesh Janardhanan, Md, Mrcp, Facc, Fase, MD, MRCP, FACC, FASE
Internal Medicine — Payments: $837,483
Internal Medicine $837,483
Steven Mottl, D.o, D.O
Internal Medicine — Payments: $317,974
Internal Medicine $317,974
Dr. Nebojsa Skrepnik, Md, MD
Internal Medicine — Payments: $315,594
Internal Medicine $315,594
Jyotsna Sahni, M.d, M.D
Internal Medicine — Payments: $150,501
Internal Medicine $150,501
Dr. Neil Gheewala, M.d, M.D
Internal Medicine — Payments: $145,873
Internal Medicine $145,873
Dr. Tara Carr, M.d, M.D
Internal Medicine — Payments: $117,865
Internal Medicine $117,865